Actis Capital
Hong Kong PE: Institutional outpost
Hong Kong's regulatory approach can cause headaches for GPs, but the territory offers investors a number of advantages as well
Actis opens Hong Kong office to focus on IR, client services
Actis has opened an office in Hong Kong that will primarily be used for investor relations and client services activities in Asia, including Australia and New Zealand. The firm already has bases in Beijing and Mumbai.
IFC proposes $100m commitment to Actis energy fund
The International Finance Corporation (IFC), the investment arm of the World Bank, has proposed a $100 million investment in Actis Capital's latest emerging markets energy fund.
Actis renewables platform to buy India solar asset
Ostro Energy, an Indian renewable energy platform backed by Actis Capital, has agreed to buy a solar power project owned by Suzlon Energy.
NewQuest buys BPO asset from Ayala, Actis
Direct secondaries specialist NewQuest Capital Partners has acquired business process outsourcing (BPO) company Integreon from Philippines conglomerate Ayala Corporation and Actis Capital.
Actis-backed Endurance Technologies files for India IPO
Indian automobile component manufacturer Endurance Technologies has filed for an IPO, providing an exit for its investor Actis.
Actis sells stake in Sri Lanka's Asiri Hospitals to TPG Growth
Actis has sold a 27.8% stake in Asiri Hospital Holdings (AHH), Sri Lanka’s largest private hospital group, to TPG Capital’s growth equity unit for LKR7.6 billion ($53.2 million).
Taiwan consumer: Dining out
Various PE firms have found success supporting Taiwan consumer brands in mainland China. But the food and beverage segment is an example of how picking the team, theme and time can make all the difference
PE backers to exit 7 Days Group to hotel operator Jin Jiang
A group of PE backers, including The Carlyle Group and Actis Capital, are set to exit Chinese budget hotel chain 7 Days Group as industry peer Shanghai Jin Jiang Hotels agreed to acquire a majority stake in the company for RMB8.3 billion ($1.3 billion).
Actis agrees exit from India's Phoenix Lamps
Private equity firm Actis has reached an agreement to exit its stake in Indian automotive lighting manufacturer Phoenix Lamps to cable maker Suprajit Engineering.
PE investors to make partial exits from India's AGS, S.H. Kelkar
Three private equity firms – TPG Capital, Actis and The Blackstone Group – are set for partial exits from their Indian investments as payment solutions provider AGS Transact Technologies and fragrances manufacturer S.H. Kelkar both filed for IPOs.
Actis invests $230m in Indian renewables platform
Emerging markets-focused UK GP Actis is investing $230 million to create an Indian renewable energy platform - Ostro Energy.
General Atlantic-backed Xiabu Xiabu targets $146m HK IPO
Xiabu Xiabu, a Chinese hotpot chain backed by General Atlantic, is seeking to raise up to HK$1.13 billion ($146 million) through a Hong Kong IPO.
Actis exits Indian retailer Nilgiri's to Future Group
Actis has exited it stake in India's Nigilri Dairy Farm , the business behind convenience store chain Nilgiri's, to Future Consumer Enterprise (FCEL), a retail unit of Kishore Biyani’s Future Group.
Actis seeks cookie fortune
Despite having an established brand name and a history that goes back over half a century, biscuit maker Jiashili has a battle on its hands. Like other Chinese snack producers, the company faces competition not only from domestic rivals but also from...
Actis invests in Chinese biscuit maker
Emerging markets investor Actis has taken a minority stake in Jiashili Food Group, one of China’s biggest biscuit companies, for an undisclosed sum.
Actis to sell Sterling Hospitals stake back to promoter
Actis will exit a 2006 investment in India’s Sterling Hospitals chain by selling its 82% shareholding back to the founder, Girish Patel. Financial terms of the deal were not disclosed.
Actis raises $1.15b for global energy fund
Actis has closed its third global energy fund - Actis Energy 3 - at $1.15 million, exceeding its original $750 million target by 50%.
Darby exits India's Symbiotec Pharmalab, Actis ups stake
Darby Private Equity, the PE arm of Franklin Templeton Investments, has exited its investment in Symbiotec Pharmalab to Actis. Financial terms were not disclosed.
Actis invests $48m in Indian pharma company
Actis has invested $48 million for a significant minority stake in Symbiotec Pharmalab, an active pharmaceutical ingredients (API) manufacturer.
Actis buys India lighting business from Halonix for $24m – update
Following an agreement in July to buy the general lighting division of portfolio company Halonix, Actis will pay an enterprise value of INR1.6 billion ($24 million) for the unit.
Actis makes another attempt to sell India’s Sterling Hospitals – report
Olympus Capital-backed DM healthcare and Temasek’s HealthCare Global (HCG) are reported to be making offers for Actis Capital's Sterling Hospitals.
Actis to buy India lighting business from Halonix
Actis is set to buy the loss-making general lighting division of its portfolio company Halonix, a manufacturer of compact fluorescent lamps for general lighting and halogen lamps for automotives.
Actis exits Chinese kitchen equipment maker to US trade buyer
Actis has sold its stakes in Chinese commercial kitchen equipment maker Vesta to Illinois Tool Works (ITW), a US industrial equipment manufacturer. Terms of the transaction were not disclosed.